DE60221151D1 - Verfahren zur bestimmung der prognose von krebspatienten mittels tucan - Google Patents

Verfahren zur bestimmung der prognose von krebspatienten mittels tucan

Info

Publication number
DE60221151D1
DE60221151D1 DE60221151T DE60221151T DE60221151D1 DE 60221151 D1 DE60221151 D1 DE 60221151D1 DE 60221151 T DE60221151 T DE 60221151T DE 60221151 T DE60221151 T DE 60221151T DE 60221151 D1 DE60221151 D1 DE 60221151D1
Authority
DE
Germany
Prior art keywords
tucan
level
prognosis
determining
patients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60221151T
Other languages
English (en)
Other versions
DE60221151T2 (de
Inventor
John C Reed
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanford Burnham Prebys Medical Discovery Institute
Original Assignee
Sanford Burnham Prebys Medical Discovery Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanford Burnham Prebys Medical Discovery Institute filed Critical Sanford Burnham Prebys Medical Discovery Institute
Priority claimed from PCT/US2002/014487 external-priority patent/WO2002090931A2/en
Publication of DE60221151D1 publication Critical patent/DE60221151D1/de
Application granted granted Critical
Publication of DE60221151T2 publication Critical patent/DE60221151T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE60221151T 2001-05-07 2002-05-07 Verfahren zur bestimmung der prognose von krebspatienten mittels tucan Expired - Fee Related DE60221151T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US28922301P 2001-05-07 2001-05-07
US289223P 2001-05-07
US35693402P 2002-02-12 2002-02-12
US356934P 2002-02-12
PCT/US2002/014487 WO2002090931A2 (en) 2001-05-07 2002-05-07 Methods for determining the prognosis for cancer patients using tucan

Publications (2)

Publication Number Publication Date
DE60221151D1 true DE60221151D1 (de) 2007-08-23
DE60221151T2 DE60221151T2 (de) 2008-03-20

Family

ID=30117968

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60221151T Expired - Fee Related DE60221151T2 (de) 2001-05-07 2002-05-07 Verfahren zur bestimmung der prognose von krebspatienten mittels tucan

Country Status (5)

Country Link
EP (1) EP1456645B1 (de)
JP (1) JP4256169B2 (de)
AT (1) ATE366938T1 (de)
CA (1) CA2446825A1 (de)
DE (1) DE60221151T2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4896994B2 (ja) * 2006-02-09 2012-03-14 ユニバーシティー オブ サウス フロリダ Ｂｃｌ−２レベルの上昇による癌の検出
IT201700003916A1 (it) * 2017-01-16 2018-07-16 Univ Degli Studi Di Verona Tampone di lisi per cellule e suoi usi in saggi per la rilevazione di una proteina cellulare o dell’attività di una proteina cellulare.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001022920A2 (en) * 1999-09-29 2001-04-05 Human Genome Sciences, Inc. Colon and colon cancer associated polynucleotides and polypeptides
EP1226162A4 (de) * 1999-10-27 2004-06-23 Millennium Pharm Inc Neue moleküle der "card-ähnlichen"-proteinfamilie und ihre verwendungen
US6110691A (en) * 2000-01-06 2000-08-29 Board Of Regents, The University Of Texas System Activators of caspases

Also Published As

Publication number Publication date
ATE366938T1 (de) 2007-08-15
JP4256169B2 (ja) 2009-04-22
JP2005501225A (ja) 2005-01-13
EP1456645B1 (de) 2007-07-11
EP1456645A2 (de) 2004-09-15
CA2446825A1 (en) 2002-11-14
EP1456645A4 (de) 2005-02-23
DE60221151T2 (de) 2008-03-20

Similar Documents

Publication Publication Date Title
ATE516742T1 (de) Verfahren zur bestimmung der optischen eigenschaften eines mehrschichtigen gewebes
ATE540319T1 (de) Verfahren für die bestimmung von fk506
HUP0302332A2 (hu) Génkimutatási eljárás ErbB-antagonistával végzett rákterápiára adott hatékony reakció valószínûségének növelésére
ATE365922T1 (de) Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6)
ATE230487T1 (de) Verfahren zur frühen diagnose von carcinomen
DE60223561D1 (de) Verfahren zum nachweis von oxidativem stress sowie kit zur durchführung davon
ATE532070T1 (de) Entzündungsmarker zum nachweis und zur prävention von diabetes mellitus
WO2005084109A3 (en) Cancer specific gene mh15
ATE520979T1 (de) Biomarker und verfahren zur bestimmung der empfindlichkeit gegenüber modulatoren des egf(epidermal growth factor)-rezeptors
BRPI0311233B8 (pt) métodos in vitro para triagem de um paciente para carcinoma hepatocelular (hcc), e para diagnosticar hcc em um paciente, bem como método e kit para detectar ou determinar o nível de gpc3 em uma amostra
ATE503846T1 (de) Verfahren zur diagnose eines ovarialkarzinoms
DE59912716D1 (de) Verfahren zur bestimmung der immunabwehraktivität des blutes sowie testkit hierfür
DE602005019156D1 (de) Verfahren zur auswertung von ribonukleotidsequenzen
DE602006011607D1 (de) In-vitro-verfahren zur identifizierung von verbindungen zur krebstherapie
ATE426043T1 (de) Verfahren zur identifizierung des brustkrebsrisikos
ATE519116T1 (de) Verfahren zur normierung der konzentration von analyten in einer urinprobe
DE602005023329D1 (de) VERFAHREN ZUR DIAGNOSE NICHT-KLEINZELLIGER LUNGENKARZINOME ÜBER DIE tRNA-DIHYDROURIDIN-SYNTHASEAKTIVITÄT VON URLC8
DE60221151D1 (de) Verfahren zur bestimmung der prognose von krebspatienten mittels tucan
DE50313393D1 (de) Verfahren zur diagnose von entzündungserkrankungen und infektionen mittels bestimmung von lasp-1/ lap-1
ATE453723T1 (de) Psoriasin-expression durch brustepithelzellen
ATE543429T1 (de) Verfahren zur bestimmung des sympathikus-tonus und messsystem dafür
RU2007148219A (ru) Способ обнаружения бактерий и тест-набор для их обнаружения
ATE481644T1 (de) Prognose des verlaufs einer krebserkrankung
ATE272718T1 (de) Verfahren zur bestimmung von disaccharidasen
WO2002090931A3 (en) Methods for determining the prognosis for cancer patients using tucan

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee